Skip to main content
. 2016 Jul 5;9:197–209. doi: 10.1016/j.mgene.2016.07.002

Table 1.

Characteristics of included studies.

Studies Study location Indication of warfarin Number of sample(ALL/M) Age INR target range Genotype frequencies
CYP2C9
CYP4F2
VKORC1 1173
VKORC1-1639
*1/*1 *1/*3 *3/*3 CC CT TT TT TC CC AA GA GG
1 Cen et al. (2010) Guangdong MHVR 222/104 45 ± 12 1.8–2.4 91.0 8.0 1.0 52.0 41.0 7.0
2 Chen et al. (2014) Beijing HVR,AF 551/308 51 (43–60) 1.6–2.5 91.2 8 0.2 52.3 38.8 8.9
3 Cheng et al. (2009) Fujian AF, HVR 248/132 68.86 ± 6.09 1.5–3.0 86.7 12.1 1.2 65.3 26.6 8.1
4 Du et al. (2010) Beijing AF,DVT,HVR,PE 190/109 60 (18–89) 1.5–3.0 91.58 8.42 0 85.79 13.16 1.05
5 Gao et al. (2010) Fujian MHVR 119/50 44.58 1.5–2.5 92.44 7.56 0 84.03 15.97 0
6 Gu et al. (2010) Chongqing MHVR 127/59 44.3 ± 17.6 1.5–2.0 85 12.6 2.4
7 Huang et al. (2009a) Guangdong HVR,AF,DVT 266/123 51.5 ± 15.0 1.8–3.0 90.2 9.4 0.4 77.4 21.1 1.5
8 Huo et al. (2008) Guangdong HVR 93/45 21–62 1.5–2.0 84.95 15.05 0
9 Jiang et al. (2007) Jiangsu / 102/51 53.6 ± 16 1.5–2.5 81.4 15.7 2.9
10 Li et al. (2012) Jiangxi MVR,AVR,DVR 352/123 61.8 ± 6.6 1.8–2.5 58 34.9 7.1
11 Li and Sheng (2010) Jiangsu HVR,AF 73/41 54.98 ± 14.10 1.5–3.0 80.82 16.44 2.74 76.71 19.18 4.11
12 Liang et al. (2012b) Beijing AF,DVT,PE,HVR 115/71 64.9 ± 13.0 2.0–3.0 92.2 7.8 0 41.7 47.8 10.4 85.2 14.8 0
13 Liang et al. (2013) Yunnan 300/138 47.9 ± 12.5 1.5–3.0 92 7.3 0.7 57.3 40 2.7
14 Liu and Zhang (2010) Beijing PE 108/46 59.02 2.0–3.0 77.78 21.3 0.92
15 Lou et al. (2012) Beijing HVR,AF 161/89 64.53 1.5–3.0 87.58 12.42 0
16 Lu et al. (2013) Jiangsu MHVR 197/82 47.0 (18–76) 1.5–2.8 94.4 5.6 0 80.7 18.8 0.5
17 Ma et al. (2012) Beijing AF,DVT,PE,HVR 312/119 56.6 ± 16.0 1.6–3.0 87.8 12.2 56.1 43.9 84.9 15.1
18 Meng et al. (2011) Jiangsu RHD, AF, DVT 125/48 51.16 1.8–3.0 87.2 12 0.8 87.2 12 0.8
19 Miao et al. (2007) Jiangsu AF,DVT,PE,HVR 178/74 54.7 1.5–3.0 91 9 0 83.7 15.7 0.6
20 Tan et al. (2013) Hunan MHVR. 317/95 45.2 ± 10.5 2.1–2.8 91.5 7.9 0.6 63.4 33.75 2.84 80.7 18 1.3
21 Tang et al. (2009) Beijing VTE 205/108 60.1 ± 13.8 2.0–3.0 86.8 12.2 1
22 Veenstra et al. (2005) Hongkong AF, DVT, RHD 69/32 58.0 ± 10.0 1.8–3.2 94.2 5.8 0 76.8 20.3 2.9
23 Wang and Zhong (2013) Sichuan Orthopedic Surgery 214/114 51.6 ± 7.5 2.0–3.0 90.7 8.4 0.9 79.9 19.2 0.9
24 Wang et al. (2011) Liaoning / 196/80 61.89 1.8–3.0 50.51 42.86 6.63
25 Wei et al. (2012) Jiangsu NVAF,DVT,MHVR 325/153 66.5 ± 12.9 1.5–3.0 90.8 9.2 0 56 33.3 10.8 86.8 12.9 0.3
26 Yang et al. (2011) Jiangsu / 178/74 55.3 1.5–3.0 86.5 12.9 0.56
27 Yuan et al. (2005) Taiwan / 104/56 58.6 ± 14.4 1.58–2.55 79.8 18.3 1.9
28 Zhang et al. (2012b) Jiangsu MHVR 197/82 52.92 ± 11.76 1.5–2.8 58.38 37.06 4.57
29 Zhang et al. (2007a) Xinjiang HVR 88/41 45.1 1.5–2.0 77.27 14.77 0
30 Zhang et al. (2012a) Beijing VTE,PE 297/148 64 2.0–3.0 91.2 8.8 0 85.5 13.8 0.7
31 Zhang et al. (2007b) Fujian RHD,AF 129/52 45.79 ± 12.06 1.5–3.0 90.7 8.15 0.8 74.42 23.26 2.3
32 Zheng et al. (2008) Beijing / 123 / / 92.68 6.5 0
33 Zhuang et al. (2014) Shanghai AF,DVT,HVR 214/110 65.72 ± 10.59 1.5–3.0 92.52 7.48 0 57.94 42.06 82.71 17.29 0